Difficulty: Medium
Average Score: 73%
Practice
Which of the following statements is CORRECT?
Correct answer
D
Rationale
In the context of chemotherapy drugs, option D is correct because it does not provide any false or misleading information. This question is likely designed to test knowledge of common misconceptions or inaccuracies related to chemotherapy treatments. By selecting option D, it demonstrates an understanding that none of the other statements are correct in the context of chemotherapy drugs.
Option A is incorrect because hydroxocobalamin is not necessarily preferred over cyanocobalamin due to rapid absorption; the choice between these two forms of vitamin B12 may depend on individual patient factors or specific treatment goals.
Option B is incorrect because ferrous salt, specifically ferrous sulfate, is typically more readily absorbed than ferric iron. This is an important distinction when considering iron supplementation in patients undergoing chemotherapy who may be at risk of anemia.
Option C is incorrect because patients on dialysis often require folic acid supplementation due to increased loss of this vitamin during the dialysis process. Folic acid is crucial for cell division and growth, and patients with kidney disease may be deficient in this vitamin.
In an educational context, understanding the nuances of chemotherapy drugs and supportive care measures is essential for healthcare providers involved in cancer treatment. This question highlights the importance of accurate knowledge in making informed decisions regarding medication selection and supportive therapies for patients undergoing chemotherapy.
Option A is incorrect because hydroxocobalamin is not necessarily preferred over cyanocobalamin due to rapid absorption; the choice between these two forms of vitamin B12 may depend on individual patient factors or specific treatment goals.
Option B is incorrect because ferrous salt, specifically ferrous sulfate, is typically more readily absorbed than ferric iron. This is an important distinction when considering iron supplementation in patients undergoing chemotherapy who may be at risk of anemia.
Option C is incorrect because patients on dialysis often require folic acid supplementation due to increased loss of this vitamin during the dialysis process. Folic acid is crucial for cell division and growth, and patients with kidney disease may be deficient in this vitamin.
In an educational context, understanding the nuances of chemotherapy drugs and supportive care measures is essential for healthcare providers involved in cancer treatment. This question highlights the importance of accurate knowledge in making informed decisions regarding medication selection and supportive therapies for patients undergoing chemotherapy.